Aktiesnakken — Juni 2011
-
salgstal, fabrikssalg, aftale på daratumumab, nyt fra lundbeck, nyt frarochestofferne
-
vestas gennembrud i stealth teknologi: http://www.vestas.com/en/media/news/news-display.aspx?action=3&NewsID=2727
-
er der ikke også nogle zalu data på trapperne?
-
jo det er der også
-
spændende aspekulant
-
nej zalu vil de bare ikke bruge penge på. men den kan få en pludselig revival ligesom cd4 fik
-
nu må jeg til møde. Vi ses om et par timer
-
, consistently exceeding both near and medium term profitable sales growth objectives."
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind